Baylor College of Medicine News

Cancer News

Newly identified network triggers degradation of important tumor suppressor protein in triple negative breast cancerNov 7, 2014
Researchers from Baylor College of Medicine have identified a network of proteins that triggers triple negative breast cancer – one of the most aggressive and difficult-to-treat forms of the disease.
Immune-related gene may predispose to HPV-related cancerOct 23, 2014
Baylor-led research identifies immune related gene that appears to play an important role in determining whether a person develops a cancer related to human papilloma virus.
$160,000 NIH grant advances mining of datasets in scientific articlesOct 21, 2014
Award will help informatics team explore ways to enable researchers to analyze or mine such datasets more easily.
Whole exome sequencing closer to becoming “new family history”Oct 20, 2014
Baylor researchers find one-fourth of patients whose DNA was submitted for clinical whole exome testing received a diagnosis related to a known genetic disease, often ending a long search for answers for them and their parents.
SRC-2 drives castration-resistant prostate cancerOct 9, 2014
Finding a blocker for the nuclear receptor coactivator known as NCoA2 or SRC-2 might solve the problem of treating advanced prostate cancer that becomes resistant to the most common treatment.
Developmental transcription factors oversee glioma sub-typesOct 6, 2014
Researchers find transcription factors NFIA, Sox10 play important roles in the development of different subtypes of deadly brain tumors.
Zong awarded NIH Director’s New Innovator Award for cancer genomicsOct 6, 2014
Dr. Chenghang “Chuck” Zong of Baylor College of Medicine has been awarded a National Institutes of Health Director’s New Innovator Award, a prestigious grant designated to support promising new scientists and their highly innovative research ideas.
Baylor, Texas Children's Cancer Center research helps determine molecular causes of Langerhans cell histiocytosisSep 12, 2014
Study helps fill in some of the bigger picture of the molecular pathology that leads to LCH, points to some potential therapeutic approaches.
Notch1 and osteoblasts play role in bone cancer initiationSep 8, 2014
Baylor study finds high levels of Notch1, a gene that helps determine cell fate, can drive cells that normally lead to bone formation to become cancerous.
Baylor College of Medicine receives additional $9.7 million in state cancer grantsAug 21, 2014
Baylor College of Medicine received $9.7 million in the newest wave of grants announced by the Cancer Prevention and Research Institute of Texas.